Through the Looking Glass: Updated Insights on Ovarian Cancer Diagnostics
Epithelial ovarian cancer (EOC) is the deadliest gynaecological malignancy and the eighth most prevalent cancer in women, with an abysmal mortality rate of two million worldwide. The existence of multiple overlapping symptoms with other gastrointestinal, genitourinary, and gynaecological maladies of...
Main Authors: | Sourav Chakraborty, Priti S. Shenoy, Megha Mehrotra, Pratham Phadte, Prerna Singh, Bharat Rekhi, Pritha Ray |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/13/4/713 |
Similar Items
-
Homo and Heterotypic Cellular Cross-Talk in Epithelial Ovarian Cancer Impart Pro-Tumorigenic Properties through Differential Activation of the Notch3 Pathway
by: Souvik Mukherjee, et al.
Published: (2022-07-01) -
Correction: Mukherjee et al. Homo and Heterotypic Cellular Cross-Talk in Epithelial Ovarian Cancer Impart Pro-Tumorigenic Properties through Differential Activation of the Notch3 Pathway. <i>Cancers</i> 2022, <i>14</i>, 3365
by: Souvik Mukherjee, et al.
Published: (2024-02-01) -
Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group
by: Grégoire Rocher, et al.
Published: (2021-03-01) -
Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer
by: Nodin Björn, et al.
Published: (2012-09-01) -
Bioinformatics analysis of FOLR1 expression, functional enrichment, related signaling pathways and relationship with prognosis in ovarian cancer
by: Wang Yan, et al.
Published: (2020-04-01)